Cytotoxicity of Esculetin Compared with Vinblastine and Paclitaxel in PC-3 Prostate Cancer Cells

A differential action of esculetin on PC-3 prostate cells may be inferred. This may be relevant for novel therapies against resistant prostate cancer.

Authors

Institutions

Publication Details

Journal
Current Oncology
Published
2025-09-20
DOI
https://doi.org/10.3390/curroncol32090526
Citations
1
Primary Topic
Cancer, Lipids, and Metabolism
Type
article
Field-Weighted Citation Impact
0.94

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cytotoxicity of Esculetin Compared with Vinblastine and Paclitaxel in PC-3 Prostate Cancer Cells

Ángel Herráez, Virginia Rubio, José C. Díez, Lilian Puebla et al.
1 citations
Current Oncology
Cancer, Lipids, and Metabolism
0.94
article

Cytotoxicity of Esculetin Compared with Vinblastine and Paclitaxel in PC-3 Prostate Cancer Cells

Ángel Herráez, Virginia Rubio, José C. Díez, Lilian Puebla, Ana I. Garcı́a-Pérez
article en
1 citations

Abstract

A differential action of esculetin on PC-3 prostate cells may be inferred. This may be relevant for novel therapies against resistant prostate cancer.

Current OncologyVol. 32(9)
Universidad de Alcalá (ES)
Universidad de Alcalá
Openalex Percentile: Top 20%
Cancer, Lipids, and Metabolism
0.94
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Cytotoxicity of Esculetin Compared with Vinblastine and Paclitaxel in PC-3 Prostate Cancer Cells — Ángel Herráez, Virginia Rubio, et al. · Current Oncology (2025) | TGRS Research Map | TGRS